{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:56:36Z","timestamp":1785232596039,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,17]],"date-time":"2027-02-17T00:00:00Z","timestamp":1802822400000},"content-version":"am","delay-in-days":231,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001380","name":"The William K Warren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbi.2026.106490","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:25:49Z","timestamp":1771287949000},"page":"106490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Changes in kynurenine pathway metabolites and brain structure in response to behavioral activation therapy"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-6802","authenticated-orcid":false,"given":"Cherry","family":"Youn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Akeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Martell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Aupperle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106490_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjmad.2023.100004","article-title":"A randomized clinical trial of behavioral activation and exposure-based therapy for adults with generalized anxiety disorder","volume":"1","author":"Berg","year":"2023","journal-title":"J. Mood Anxiety Disorders"},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cpr.2005.07.003","article-title":"The empirical status of cognitive-behavioral therapy: a review of meta-analyses","volume":"26","author":"Butler","year":"2006","journal-title":"Clin. Psychol. Rev."},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1176\/appi.ajp.161.4.598","article-title":"Lower hippocampal volume in patients suffering from depression: a meta-analysis","volume":"161","author":"Campbell","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106490_b0020","doi-asserted-by":"crossref","unstructured":"Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., DeWalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Lai, J. S., Pilkonis, P., Revicki, D., Rose, M., \u2026 PROMIS Cooperative Group (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.Journal of clinical epidemiology,63(11), 1179\u20131194.","DOI":"10.1016\/j.jclinepi.2010.04.011"},{"issue":"4548","key":"10.1016\/j.bbi.2026.106490_b0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.7079744","article-title":"Anticonvulsant action of excitatory amino acid antagonists","volume":"216","author":"Croucher","year":"1982","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbi.2026.106490_b0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/acps.13335","article-title":"The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: a meta\u2010analysis","volume":"144","author":"Cuijpers","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1534582305276837","article-title":"Brain lateralization of emotional processing: historical roots and a future incorporating \u201cdominance\u201d","volume":"4","author":"Demaree","year":"2005","journal-title":"Behav. Cogn. Neurosci. Rev."},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2010.06.010","article-title":"Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature","volume":"53","author":"Destrieux","year":"2010","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-032210-104535","article-title":"The origins and current status of behavioral activation treatments for depression","volume":"7","author":"Dimidjian","year":"2011","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0050","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1037\/0022-006X.74.4.658","article-title":"Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression","volume":"74","author":"Dimidjian","year":"2006","journal-title":"J. Consult. Clin. Psychol."},{"issue":"20","key":"10.1016\/j.bbi.2026.106490_b0055","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bbi.2026.106490_b0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bbi.2026.106490_b0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0070","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jts.22678","article-title":"Changes in brain volume associated with trauma\u2010focused cognitive behavioral therapy among youth with posttraumatic stress disorder","volume":"34","author":"Garrett","year":"2021","journal-title":"J. Trauma. Stress"},{"issue":"11","key":"10.1016\/j.bbi.2026.106490_b0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mp.2008.57","article-title":"Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"13","author":"Hamilton","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2026.106490_b0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.bbi.2026.106490_b0095","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.npp.1300371","article-title":"Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression","volume":"29","author":"Hastings","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.bbi.2026.106490_b0105","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/hbm.20801","article-title":"Brain volume abnormalities in major depressive disorder: a meta\u2010analysis of magnetic resonance imaging studies","volume":"30","author":"Koolschijn","year":"2009","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.bp.113.140376","article-title":"Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder","volume":"205","author":"Korgaonkar","year":"2014","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.bbi.2026.106490_b0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2020.01.101","article-title":"Minimally important differences and severity thresholds are estimated for the PROMIS depression scales from three randomized clinical trials","volume":"266","author":"Kroenke","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.bbi.2026.106490_b0120","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11682-023-00797-z","article-title":"Gray matter abnormalities in patients with major depressive disorder and social anxiety disorder: a voxel-based meta-analysis","volume":"17","author":"Liang","year":"2023","journal-title":"Brain Imaging Behav."},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0125","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1038\/tp.2014.21","article-title":"Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression","volume":"4","author":"Lyden","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106490_b0130","series-title":"Behavioral activation for depression: a clinician's guide","author":"Martell","year":"2021"},{"issue":"10","key":"10.1016\/j.bbi.2026.106490_b0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tics.2011.08.002","article-title":"Experience-dependent structural plasticity in the adult human brain","volume":"15","author":"May","year":"2011","journal-title":"Trends Cogn. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1139\/jpn.0905","article-title":"A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder","volume":"34","author":"McKinnon","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2026.106490_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106490_b0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpsychires.2021.02.001","article-title":"Cognitive behavioral therapy for patients with mild to moderate depression: treatment effects and neural mechanisms","volume":"136","author":"Meng","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.bbi.2026.106490_b0155","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2026.106490_b0160","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1523\/JNEUROSCI.05-11-02909.1985","article-title":"Distribution of N-methyl-D-aspartate-sensitive L-[3H] glutamate-binding sites in rat brain","volume":"5","author":"Monaghan","year":"1985","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2026.106490_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2026.106490_b0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"5669","key":"10.1016\/j.bbi.2026.106490_b0175","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.1094285","article-title":"Dissociable roles of ventral and dorsal striatum in instrumental conditioning","volume":"304","author":"O'Doherty","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbi.2026.106490_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"16","key":"10.1016\/j.bbi.2026.106490_b0185","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1523\/JNEUROSCI.2524-16.2017","article-title":"Effort-based reinforcement processing and functional connectivity underlying amotivation in medicated patients with depression and schizophrenia","volume":"37","author":"Park","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106490_b0195","doi-asserted-by":"crossref","unstructured":"Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., Cella, D., & PROMIS Cooperative Group (2011). Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS\u00ae): depression, anxiety, and anger.Assessment,18(3), 263\u2013283.","DOI":"10.1177\/1073191111411667"},{"key":"10.1016\/j.bbi.2026.106490_b0200","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"10.1016\/j.bbi.2026.106490_b0205","doi-asserted-by":"crossref","unstructured":"Redlich, R., Zwiky, E., Borgers, T., Klug, M., Koenig, P., Sch\u00f6niger, K., Selle, J., K\u00fcttner, A., Brunner, L., Leehr, E., Dannlowski, U. & Enneking, V. (2025). Limbic gray matter increases in response to cognitive-behavioral therapy in major depressive disorder.","DOI":"10.21203\/rs.3.rs-5607437\/v1"},{"issue":"6","key":"10.1016\/j.bbi.2026.106490_b0210","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.neuron.2012.01.025","article-title":"Learning in the fast lane: new insights into neuroplasticity","volume":"73","author":"Sagi","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13063-019-3802-9","article-title":"Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder","volume":"21","author":"Santiago","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.bbi.2026.106490_b0220","series-title":"Role of kynurenine metabolism pathway activation in major depressive disorders","first-page":"249","author":"Savitz","year":"2016"},{"key":"10.1016\/j.bbi.2026.106490_b0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbi.2022.01.021","article-title":"Blood versus cerebrospinal fluid: kynurenine pathway metabolites in depression","volume":"101","author":"Savitz","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2026.106490_b0235","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neubiorev.2009.01.004","article-title":"Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide","volume":"33","author":"Savitz","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"13","key":"10.1016\/j.bbi.2026.106490_b0240","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1017\/S0033291720004389","article-title":"Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid","volume":"52","author":"Savitz","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2026.106490_b0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.07.609","article-title":"Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder","volume":"62","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2026.106490_b0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","article-title":"Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder","volume":"52","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.bbi.2026.106490_b0255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2026.106490_b0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.bbi.2026.106490_b0265","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2026.106490_b0270","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2026.106490_b0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(82)90134-3","article-title":"\u03b1-Amino-\u03c9-phosphono carboxylates block ibotenate but not kainate neurotoxicity in rat hippocampus","volume":"33","author":"Schwarcz","year":"1982","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.bbi.2026.106490_b0280","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jpain.2013.07.020","article-title":"Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain","volume":"14","author":"Seminowicz","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.bbi.2026.106490_b0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jad.2014.06.043","article-title":"Relapse rates after psychotherapy for depression \u2013stable long-term effects? a meta-analysis","volume":"168","author":"Steinert","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2026.106490_b0290","article-title":"Treatment-specific hippocampal subfield volume changes with antidepressant medication or cognitive-behavior therapy in treatment-na\u00efve depression","volume":"12","author":"Tai","year":"2021","journal-title":"Front. Psych."},{"issue":"5","key":"10.1016\/j.bbi.2026.106490_b0295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00702-022-02513-5","article-title":"Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents \u2013in celebration of 80th birthday of Professor Peter Riederer","volume":"129","author":"Tanaka","year":"2022","journal-title":"J. Neural Transm."},{"issue":"9","key":"10.1016\/j.bbi.2026.106490_b0300","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2026.106490_b0305","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal volume and depression: a meta-analysis of MRI studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"76","key":"10.1016\/j.bbi.2026.106490_b0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.53841\/bpspag.2010.1.76.14","article-title":"The reliable change index: why isn\u2019t it more popular in academic psychology?","volume":"1","author":"Zahra","year":"2010","journal-title":"PsyPag Quarterly"},{"issue":"4","key":"10.1016\/j.bbi.2026.106490_b0315","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1\u03b2: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:33:46Z","timestamp":1781062426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S0889159126002382"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106490","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in kynurenine pathway metabolites and brain structure in response to behavioral activation therapy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106490"}}